Loading company…
Origin.bio develops AI-based tools for biological research and data analysis.
Founded in 2020 and based in Pullach, Germany, Origin.bio develops biotechnology tools that use artificial intelligence to analyze biological data. The company serves research and commercial applications in areas including pharmaceuticals, agriculture, and environmental science. In April 2021, it raised USD 15.00 mn in Seed funding led by EQT, with participation from Acequia Capital, BlueYard Capital, and Inventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in